Evidence map›Paper›PMID 33694262›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2021

Regional differences in office and self-measured home heart rates in Asian hypertensive patients: AsiaBP@Home study.

Naoko Tomitani, Satoshi Hoshide, Peera Buranakitjaroen, Yook Chin Chia, Sungha Park, Chen-Huan Chen, Jennifer Nailes, Jinho Shin, Saulat Siddique, Jorge Sison and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. The HOPE Asia Network activity 2022: Towards better hypertension management in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2022
    Article
  4. Latest hypertension research to inform clinical practice in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 12 countries.

Naoko TomitaniDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Peera BuranakitjaroenDivision of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Yook Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Chen-Huan ChenDepartment of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Jennifer NailesUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.
Jorge SisonDepartment of Medicine, Medical Center Manila, Manila, Philippines.
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruMIOT International Hospital, Chennai, India.
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore.
Yuda TuranaDepartment of Neurology, School of Medicine and Health Science, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sirisawat WanthongDivision of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Noriko MatsushitaOmron Healthcare Singapore, Pte. Ltd., Singapore City, Singapore.
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
HOPE Asia Network
Jichi Medical University · JPMahidol University · THAtma Jaya Catholic University of Indonesia · IDFu Wai Hospital · CNHanyang University Medical Center · KRMadras Institute of Orthopaedics and Traumatology · INNational Taipei University · TWOmron (Japan) · JPPelita Harapan University · IDPunjab Medical Center · PKShanghai Institute of Hypertension · CNTan Tock Seng Hospital · SGUniversity of Malaya · MYUniversity of the East Ramon Magsaysay Memorial Medical Center · PHYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased heart rate is a predictor of cardiovascular disease, heart failure, and all-cause mortality. In those with high heart rates, interventions for heart rate reduction have been associated with reductions in coronary events. Asia is a diverse continent, and the prevalences of hypertension and cardiovascular disease differ among its countries. The present analysis of AsiaBP@Home study data investigated differences among resting heart rates (RHRs) in 1443 hypertensive patients from three Asian regions: East Asia (N = 595), Southeast Asia (N = 680), and South Asia (N = 168). This is the first study to investigate self-measured RHR values in different Asian countries/regions using the same validated home BP monitoring device (Omron HEM-7130-AP/HEM-7131-E). Subjects in South Asia had higher RHR values compared with the other two regions, and the regional tendency found in RHR values was different from that found in BP values. Even after adjusting for age, sex, BMI, habitual alcohol consumption, current smoking habit, shift worker, hyperlipidemia, diabetes, chronic kidney disease, history of heart failure, and beta-blocker use, both office and home RHR values in South Asia were the highest among Asia (mean values ± SE of office: East Asia [E] 75.2 ± 1.5 bpm, Southeast Asia [Se] 76.7 ± 1.5 bpm, South Asia [S] 81.9 ± 1.4 bpm; home morning: [E] 69.0 ± 1.2 bpm, [Se] 72.9 ± 1.2 bpm, [S] 74.9 ± 1.1 bpm; home evening: [E] 74.6 ± 1.2 bpm, [Se] 78.3 ± 1.2 bpm, [S] 83.8 ± 1.1 bpm). Given what is known about the impact of RHR on heart disease, our findings suggest the possible benefit of regionally tailored clinical strategies for cardiovascular disease prevention.

Indexed as

HypertensionAsiaBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryHeart RateHumansAsiaAsiaBP@Home studyresting heart rateself-measured home heart ratevalidated blood pressure monitoring device

Identifiers

PMID33694262
PMCPMC8029517
OpenAlexW3134724390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.